Strides gets nod for drug; share up 2.47%

MUMBAI: Strides Arcolab Ltd has received ANDS approval for Ondansetron Injection 2 mg / ml. The product is licensed to an undisclosed partner in Canada and expects sales to commence in Q4 2007.

Ondansetron is the first amongst various sterile submissions the company has submitted with Health Canada.

On the Bombay Stock Exchange today, the Strides Arcolab share was up 2.47% at Rs 280.50.